Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Modulight Q3'25 preview: Quantum computing project shapes the quarter

By Antti SiltanenAnalyst
Modulight

Summary

  • Modulight's Q3'25 revenue is forecasted at 1.90 MEUR, indicating significant growth from Q3'24's 0.64 MEUR, driven by increased care facilities and a strong order book.
  • The EBIT forecast for Q3'25 is -1.33 MEUR, showing improvement from Q3'24's -2.11 MEUR, attributed to better gross margins and controlled operating expenses.
  • Despite positive revenue growth, Modulight continues to face losses, with a full-year 2025 revenue forecast of 8.0 MEUR and an EBIT forecast of -5.4 MEUR, reflecting an improvement from 2024.
  • Uncertainty remains due to the timing of the quantum computing project and recent change negotiations, impacting visibility into future business developments.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 10/22/2025 at 7:00 am EEST.

Estimates Q3'24Q3'25Q3'25eQ3'25eConsensus2025e
MEUR / EUR ComparisonRealizedInderesConsensusHigh LowInderes
Revenue 0.64 1.9    8
EBIT -2.11 -1.33    -5.4
EPS (reported) -0.05 -0.03    -0.12
          
Revenue growth, % 57.60% 196.90%    95.30%
EBIT % (adj.) -329.40% -70.00%    -67.20%

Source: Inderes

Modulight will publish its Q3 results on Friday, October 24 at 1:00 pm EEST. The company has shown signs of improvement in recent quarters. We expect to see a clear improvement in Q3 compared to the weak comparison period. Due in part to the timing of the quantum computing project, there is uncertainty in the Q3 figures. During the quarter, the company conducted change negotiations, the scope of which was smaller than preliminary estimates suggested. Visibility into business development remains low, so further information on future developments is welcome.

Order book and increased number of care facilities support revenue

Modulight's current year has been marked by improved development and revenue growth, despite continued losses. This positive development has been driven by growth in the number of care facilities using Modulight products and an increase in the order book. An order of 0.8 MEUR for quantum computing also supported the Q2 figures, and we expect the project to carry over into Q3. However, the lack of detailed information on the timing may lead to surprises in the report. Our Q3 revenue forecast of 1.90 MEUR implies strong growth from the weak comparison period (Q3’24: 0.64 MEUR) and steady development compared to the previous quarter. We expect the Phase III clinical trials announced earlier to generate recurring revenue through ongoing patient enrollment. Revenue is also generated by the ophthalmic laser commercialized in the US starting from 2023, as well as several smaller projects, as is typical.

Our EBIT forecast of -1.33 MEUR signals an improvement from the comparison period (Q3’24: -2.11 MEUR). The forecast is based on an improving gross margin and control of operating expenses. We expect depreciation to increase, which will weigh on the reported result. Modulight capitalizes development costs on its balance sheet, and their total exceeds the level of depreciation. For this reason, the reported result paints a more optimistic picture of the company's earnings performance than cash flow does. Modulight’s net cash was 8.8 MEUR and its cash reserves were 12.3 MEUR. Profitable growth naturally needs to start fairly soon to achieve an earnings turnaround and ensure sufficient cash reserves. During Q3, Modulight held change negotiations that led to layoffs. No further details were provided regarding the timing or duration of the layoffs, so additional information in the report will result in moderate changes to our cost estimates.

Expecting a year of budding growth and reduced losses

Modulight does not provide guidance, but the company's strategic goal for 2023-2025 is strong annual revenue growth and strong profitability at the EBITDA level. These targets were not achieved during the first two years of the strategy period, but there have been upward developments over the past year. The signs are still tentative, and visibility on future developments is low. Therefore, the progress of the earnings turnaround is still uncertain. For the full year 2025, we expect revenue of 8.0 MEUR, but we note that our forecasts have been overly optimistic so far. Our EBIT forecast for 2025 is -5.4 MEUR, which means an improvement on the comparison period (2024e: -8.1 MEUR). The view is based on growing revenue and gross margin, as well as continued tight cost control.

Login required

This content is only available for logged in users

Create account

Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.

Read more on company page

Key Estimate Figures25.08.

202425e26e
Revenue4.18.010.8
growth-%1.7 %95.3 %35.6 %
EBIT (adj.)-8.3-5.4-4.5
EBIT-% (adj.)-203.5 %-67.2 %-41.4 %
EPS (adj.)-0.15-0.12-0.09
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

Has there been any significant or noteworthy development in the IQM and Modulight quantum computing collaboration, or is it just a basic partnership...
yesterday
by Salkunvartija97
1
Good company presentation. Exuding confidence. Also remembered the 2024 talks about commercialization. Now said that there hasn’t been anything...
11/27/2025, 8:20 PM
by Jopinaattori
1
A new, just under half an hour long Modu and Orsila.https://youtu.be/tk0nQENR9DU?si=9MU7U32q6KifMSdf&t=4
11/27/2025, 7:14 PM
by Maakinen
3
My previous message in the thread 4 years ago. Modu designs lasers, which is potentially a very lucrative part of the value chain, if it can...
11/27/2025, 6:20 PM
by Clark kent
5
I also recently invested a bit in Modulight. I’ve also noticed the quietness; it’s clearly the quietest company among my investments.
11/27/2025, 3:19 PM
by Salkunvartija97
1
It’s quiet, regrettably quiet. Trading is almost at zero. This is how the years pass, big promises have turned into silence.
11/27/2025, 3:11 PM
by Skipper
1
Orsila has bought 21,000 units. A good sign for me.
10/29/2025, 9:08 AM
by Jopinaattori
8
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.